Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2024 ASH Annual Meeting
42nd Annual Chemotherapy Foundation Symposium
2024 NCCN Annual Congress: Hematologic Malignancies
IASLC 2024 Asia Conference on Lung Cancer
FDA-ASCO Virtual Workshop: Measuring Toxicity in Reproductive Organs During Oncology Drug Development
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
NCCN 2018 Annual Congress: Hematologic Malignancies
«
1
»
Advertisement
Advertisement
Nov
22
Today In Oncology
Firefighters May Be Exposed to Chemicals Associated With Breast Cancer
FDA Grants Accelerated Approval to Zanidatamab-hrii for Previously Treated Unresectable or Metastatic HER2-Positive Biliary Tract Cancer
Novel EGFR Inhibitor Firmonertinib Shows Activity in Rare Subtype of NSCLC
Outcomes of Immune Checkpoint Inhibitor Treatment for Cancer in Black vs White Patients in the U.S. VHA System
Pooled Analysis of Long-Term Outcomes With Nivolumab With or Without Ipilimumab in Advanced Melanoma
View More
Advertisement
